Dr. Reoux is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1660 S Columbian Way
Vapshcs/116-Atc
Seattle, WA 98108Phone+1 206-277-1747
Education & Training
- University of California (Irvine)Residency, Psychiatry, 1985 - 1989
- McGovern Medical School at UTHealthClass of 1985
Certifications & Licensure
- WA State Medical License 1996 - 2026
- SC State Medical License 1992 - 1996
- AK State Medical License 1989 - 1994
- TX State Medical License 1987 - 1988
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms Start of enrollment: 2004 Sep 01
Publications & Presentations
PubMed
- 13 citationsThe Alcohol Use Disorders Identification Test (AUDIT) predicts alcohol withdrawal symptoms during inpatient detoxification.Joseph P. Reoux, Carol A. Malte, Daniel R. Kivlahan, Andrew J. Saxon
Journal of Addictive Diseases. 2002-01-01 - 82 citationsDivalproex Sodium in Alcohol Withdrawal: A Randomized Double‐Blind Placebo‐Controlled Clinical TrialJoseph P. Reoux, Andrew J. Saxon, Carol A. Malte, John S. Baer, Kevin L. Sloan
Alcoholism, Clinical and Experimental Research. 2001-09-01 - 38 citationsA double-blind, double-dummy, randomized, prospective pilot study of the partial Mu opiate agonist, buprenorphine, for acute detoxification from heroinMichael R. Oreskovich, Andrew J. Saxon, Mei Ling K. Ellis, Carol A. Malte, Joseph P. Reoux
Drug and Alcohol Dependence. 2005-01-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: